News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
37,298 Results
Type
Article (1765)
Company Profile (3)
Press Release (35530)
Section
Business (15622)
Career Advice (80)
Deals (2761)
Drug Delivery (3)
Drug Development (3888)
Employer Resources (3)
FDA (789)
Job Trends (821)
News (22192)
Policy (1208)
Tag
Academia (50)
Adcomms (1)
Allergies (4)
Alliances (1531)
ALS (8)
Alzheimer's disease (60)
Antibody-drug conjugate (ADC) (4)
Approvals (805)
Artificial intelligence (16)
Bankruptcy (16)
Best Places to Work (680)
Biosimilars (5)
Biotechnology (3)
Bladder cancer (4)
Breast cancer (38)
Cancer (204)
Cardiovascular disease (14)
Career advice (71)
Career pathing (1)
CAR-T (3)
CDC (1)
Cell therapy (11)
Cervical cancer (2)
Clinical research (3551)
Collaboration (31)
Compensation (32)
COVID-19 (64)
C-suite (4)
Cystic fibrosis (6)
Data (226)
Depression (2)
Diabetes (20)
Diagnostics (392)
Digital health (2)
Diversity, equity & inclusion (1)
Drug discovery (5)
Drug pricing (2)
Drug shortages (3)
Duchenne muscular dystrophy (7)
Earnings (13453)
Employer resources (2)
Events (3714)
Executive appointments (16)
FDA (919)
Funding (37)
Gene editing (3)
Generative AI (1)
Gene therapy (13)
GLP-1 (46)
Government (109)
Guidances (55)
Healthcare (1040)
Immunology and inflammation (5)
Immuno-oncology (2)
Indications (3)
Infectious disease (73)
Inflammatory bowel disease (11)
Influenza (1)
Intellectual property (4)
Interviews (20)
IPO (1909)
Job creations (192)
Job search strategy (42)
Labor market (8)
Layoffs (27)
Legal (252)
Liver cancer (2)
Lung cancer (40)
Lymphoma (33)
Manufacturing (21)
MASH (2)
Medical device (843)
Medtech (843)
Mergers & acquisitions (882)
Metabolic disorders (53)
Multiple sclerosis (7)
NASH (1)
Neurodegenerative disease (5)
Neuropsychiatric disorders (1)
Neuroscience (94)
NextGen: Class of 2025 (229)
Non-profit (124)
Obesity (34)
Opinion (4)
Ovarian cancer (7)
Pain (5)
Pancreatic cancer (10)
Parkinson's disease (5)
Partnered (1)
Patents (9)
Patient recruitment (2)
Peanut (4)
People (1104)
Phase I (819)
Phase II (1478)
Phase III (1434)
Pipeline (302)
Policy (1)
Postmarket research (178)
Preclinical (255)
Press Release (1)
Prostate cancer (3)
Psychedelics (1)
Radiopharmaceuticals (13)
Rare diseases (22)
Real estate (204)
Recruiting (2)
Regulatory (963)
Reports (5)
Research institute (53)
Resumes & cover letters (20)
RSV (2)
Schizophrenia (9)
Series A (4)
Series B (2)
Service/supplier (1)
Sickle cell disease (3)
Spinal muscular atrophy (15)
Startups (126)
Stomach cancer (1)
Supply chain (2)
The Weekly (1)
Vaccines (18)
Venture capital (3)
Weight loss (18)
Women's health (1)
Date
Today (1)
Last 7 days (14)
Last 30 days (100)
Last 365 days (2279)
2025 (1163)
2024 (2553)
2023 (2683)
2022 (3033)
2021 (3030)
2020 (2816)
2019 (2109)
2018 (1733)
2017 (1544)
2016 (1167)
2015 (1394)
2014 (990)
2013 (690)
2012 (729)
2011 (844)
2010 (6529)
Location
Africa (29)
Alabama (3)
Arizona (9)
Asia (2087)
Australia (223)
California (506)
Canada (138)
China (40)
Colorado (23)
Connecticut (25)
Delaware (42)
Europe (4696)
Florida (64)
Georgia (20)
Idaho (4)
Illinois (54)
India (3)
Indiana (47)
Japan (18)
Kansas (5)
Kentucky (2)
Louisiana (3)
Maine (5)
Maryland (58)
Massachusetts (325)
Michigan (18)
Minnesota (25)
Missouri (1)
Montana (2)
Nebraska (1)
Nevada (1)
New Hampshire (9)
New Jersey (180)
New Mexico (2)
New York (182)
North Carolina (62)
Northern California (264)
Ohio (14)
Oregon (2)
Pennsylvania (126)
Puerto Rico (1)
Rhode Island (1)
South America (60)
South Carolina (4)
Southern California (165)
Tennessee (5)
Texas (49)
United States (1905)
Utah (22)
Virginia (4)
Washington D.C. (2)
Washington State (38)
Wisconsin (3)
37,298 Results for "125".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
ORIC® Pharmaceuticals Announces $125 Million Private Placement Financing
May 29, 2025
·
6 min read
Mergers & acquisitions
BioNTech Swallows Vaccine Rival CureVac in $1.25B All-Stock Acquisition
BioNTech will get CureVac’s early-stage cancer assets, including its mRNA-based glioblastoma therapy currently in Phase I development. CureVac had previously sued BioNTech for copyright infringement related to mRNA vaccine technology.
June 12, 2025
·
3 min read
·
Tristan Manalac
Press Releases
Myosin Therapeutics Receives FDA Clearance to Initiate First-in-Human Trial of MT-125 in Glioblastoma
June 10, 2025
·
2 min read
Press Releases
MicroPure Genomics Awarded Competitive $1.25M SBIR Phase II Grant from the National Science Foundation
June 25, 2025
·
2 min read
Press Releases
ForSight Robotics Secures $125M in Series B Funding, Addressing Global Surgeon Shortage and Exploding Demand for Ophthalmic Surgery
June 24, 2025
·
4 min read
Press Releases
TOLREMO therapeutics Announces TT125-802 is the First CBP/p300 Bromodomain Inhibitor to Show Clinical Activity in Solid Tumors
June 4, 2025
·
3 min read
Press Releases
Cellectar Biosciences Submits Phase 1b Clinical Trial Protocol to US Food and Drug Administration for CLR 125 to Treat Triple-Negative Breast Cancer (TNBC)
June 24, 2025
·
6 min read
Press Releases
FDA Approves New, Low-Dose Chlorthalidone for the Treatment of Hypertension in Adults: HemiClor™ (12.5 mg chlorthalidone)
May 7, 2025
·
4 min read
Press Releases
Tarsus Announces Pricing of Upsized $125.0 Million Public Offering
March 13, 2025
·
4 min read
Press Releases
NextPoint Therapeutics to Showcase Pioneering Preclinical Data on NPX125, a Novel B7-H7 Targeted Antibody-Drug Conjugate (ADC) at AACR Annual Meeting 2025
April 25, 2025
·
3 min read
1 of 3,730
Next
